“Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial”, J of Skin, vol. 9, no. 2, p. s534, Mar. 2025, doi: 10.25251/skin.10.supp.534.